Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 2Head & Neck 2Genitourinary 2Dermatologic 2Breast 2Plasma cell 1Other hematologic neoplasm 1Other 1Lymphoid 1Endocrine 1

Conditions

Neoplasms 2

Interventions

Surveys and Questionnaires 70Blood Specimen Collection 48Radiotherapy 39Magnetic Resonance Spectroscopy 35pembrolizumab 31Gemcitabine 30Bevacizumab 30Nivolumab 29Carboplatin 29Radiosurgery 27Standard of Care 26Oxaliplatin 26Capecitabine 25Paclitaxel 24Interviews as Topic 24Cisplatin 24Fluorouracil 23Erlotinib Hydrochloride 22Everolimus 19Irinotecan 18Trastuzumab 17Methods 17Exercise 17Docetaxel 17Biopsy 17Cyclophosphamide 16Educational Status 15Sorafenib 14Ipilimumab 14Fluorodeoxyglucose F18 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Water × Tumor-Agnostic × Clear all
NCT01243333 2024-04-17

Multi-Tracer Positron Emission Tomography in Patients With Solid Tumors

University of Utah

Phase NA Terminated
26 enrolled 11 charts
Tumor-Agnostic

Neoplasms

NCT02173964 2016-04-15

Pinverin Application Trial to Reduce Bowel Uptake of FDG (Fluorodeoxyglucose)

Seoul National University Hospital

Phase 4 Completed
58 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡